Efficient Methods of Human Leukocyte Antigen Capture in a Point of Care Setting

164504-Thumbnail Image.png
Description

The Human Leukocyte Antigen (HLA) is a protein on the surface of cells that is a large component of the adaptive immune response as it helps recognize foreign pathogenic material. We wonder if a set of primers designed for each

The Human Leukocyte Antigen (HLA) is a protein on the surface of cells that is a large component of the adaptive immune response as it helps recognize foreign pathogenic material. We wonder if a set of primers designed for each HLA type could be used to amplify a wide spectrum of HLA to improve sequencing of HLA to improve HLA-typing access. We propose the use of an HLA allele panel to determine the pulldown capacity of the primers followed by MinION sequencing and also offer a multiplexing design for running 96 patients at once. Our results show that primers can capture Class I HLA alleles and typing was successful with an average alignment accuracy of 91.7%. In conclusion this method for HLA capture could be utilized for HLA-typing with material costs of under $3.00 per sample within 3 days.

Date Created
2022-05
Agent

High-Throughput Antigen Screening via an Invariant Chain Fusion Protein & the MHC Class II Receptor

Description
The human body’s immune system utilizes many different cell types, signaling proteins, and receptors to thwart an infectious pathogen from an individual. Adaptive immunity, particularly with CD4+ T cell lymphocytes & the MHC II receptor, was the focus of this

The human body’s immune system utilizes many different cell types, signaling proteins, and receptors to thwart an infectious pathogen from an individual. Adaptive immunity, particularly with CD4+ T cell lymphocytes & the MHC II receptor, was the focus of this paper by creating a custom destination vector plasmid, pFLIiP, which would contain a gateway cloning site and the nucleotides encoding the first 85 amino acids of the invariant chain protein upstream to provide a means of high-throughput antigen screening via the MHC II receptor and peptide processing pathway. The plasmid pFLIiP was successfully created and sequence verified. Both GFP and mCherry fluorescent proteins were inserted into pFLIiP via LR Clonase and successfully transfected into K562 cancer cells. Fluorescent activity read of a flow cytometer in conjunction with the differing pKa values of the two different fluorescent proteins suggested the fusion protein was in-frame and pFLIiP was successfully targeting the protein to the endosome.
Date Created
2020-05
Agent